Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 2,191 shares at $11.52 ($25K) on 2024-09-09, disclosed to the SEC on 2024-09-09.
Open-market sale of $25k TVTX by CHIEF COMMERCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |